Comprehensive Cancer Center
Bringing Together The Best Minds In Medicine
Our five multidisciplinary research programs are led by some of the world’s most expert cancer scientists and clinicians. Through constant collaboration and interaction between all programs, we can deliver new treatments capable of improving outcomes for patients here, across the U.S. and around the world.
The program’s mission is to advance the science and application of cancer etiology, prevention and outcomes research, and to reduce the burden of cancer across all segments of the population through collaborative, interdisciplinary, interventional and educational efforts. All research associated with Cancer Control and Population Sciences involves strong educational components, ranging from K-through-12 programs in the community to health care provider and caregiver training designed to enable better communication and care for cancer survivors.
Our team of cancer immunotherapeutics researchers are focused on the discovery and application of more specific and less toxic cancer therapies, and translating those therapies into clinical practice. Research in the program has yielded a growing portfolio of active investigational new drugs. New Food and Drug Administration-authorized therapies impact a growing number of patients, including those with glioma, lymphoma, childhood neuroblastoma and colorectal, breast and prostate cancers.
The search for more effective, less toxic treatments for cancer is an ongoing and vital pursuit at City of Hope. In our Developmental Cancer Therapeutics Program, research scientists and clinicians are collaborating closely to develop and evaluate novel therapies for cancer patient. The program team develops targeted and selective anti-cancer treatments to reduce the amount of collateral damage to normal tissues associated with many currently available treatments. These leading-edge studies are leading to greatly improved cancer therapies, with further advances expected to continue.
Bringing together clinical and basic scientists in dynamic ways, intensive studies within the leading-edge Hematologic Malignancies Program bring basic science research findings to the clinic to target and treat the transformed cells in the blood, lymph nodes and bone marrow that generate malignant blood cancers. The Hematologic Malignancies Program improves public health, particularly in the underserved populations in the catchment areas of the cancer center, both through its refinement of currently available treatment options for hematological malignancies and its advancement of novel therapies to the clinic.
The mission of the Molecular and Cellular Biology of Cancer Program is to advance basic research in cancer biology and accelerate the application of basic cancer science into the clinic for cancer prevention and therapeutics. To achieve this, the program brings together world-class investigators in the areas of DNA damage response and repair, RNA biology and therapeutics, cancer metabolism and oncogenic signaling.
As an independent, National Cancer Institute-designated comprehensive cancer center, City of Hope brings a uniquely integrated model to patients spanning personalized cancer care, research and development, academics and training, and innovation initiatives.
Why choose a comprehensive care center?
Meet the people leading our mission to eliminate cancer.
At City of Hope, we go beyond talking about standard treatments to provide educational opportunities that truly explore the latest advancements in research and therapies. With state-of-the-art laboratories as classrooms and renowned scientists as teachers and mentors, City of Hope's postgraduate education equips researchers and physicians with the skills to transform the future of medicine.
City of Hope's comprehensive cancer center uses its research and resources to improve the lives of the men, women and children in our communities. We are especially engaged in our most vulnerable communities representing cancer care deserts; these regions include the Antelope Valley and the Inland Empire (San Bernardino and Riverside counties). Therefore, the people, families and communities we serve face challenges that increase cancer risk and survival — including poverty, obesity and lack of access to care.
City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. Our infrastructure and collaborative energy set us apart. By having scientists, treatment staff and manufacturing facilities side-by-side, our treatment advances can travel from laboratory to patient with lifesaving speed.